Xiaoqiang Chang | Molecular Medicine | Best Research Article Award

Posted on by sciencefather

Dr. Xiaoqiang Chang | Molecular Medicine | Best Research Article Award 

Doctorate, at School of Pharmacy, China.

Dr. Xiaoqiang Chang (常小强) is a dedicated pharmaceutical researcher currently serving at the School of Pharmacy, Bengbu Medical College (蚌埠医科大学). He earned his Ph.D. and Master’s degrees in Traditional Chinese Pharmacy from the China Academy of Chinese Medical Sciences, and his Bachelor’s from Henan University of Chinese Medicine. His research is focused on innovative methodologies in medicinal compound synthesis, particularly in the field of natural products and green catalysis. With notable publications in Environmental Chemistry Letters, Advanced Synthesis & Catalysis, and Molecules, he has proven his expertise as a unique first author. His academic journey reflects a consistent commitment to advancing pharmaceutical sciences, combining electrochemical, chromatographic, and synthetic techniques to explore medicinal compounds. Dr. Chang also holds a Chinese patent on diphenyldiazepine derivatives. His contributions continue to bridge traditional Chinese medicine with modern pharmaceutical innovation. 🌿⚗️📚

Professional Profile

ORCID

🎓 Education 

Dr. Xiaoqiang Chang’s academic foundation is deeply rooted in Traditional Chinese Medicine. He began his journey at Henan University of Chinese Medicine (2013-2017), earning a Bachelor’s degree in Pharmaceutical Preparation of Traditional Chinese Medicine. Driven by a passion for scientific research, he pursued graduate studies at the prestigious China Academy of Chinese Medical Sciences, obtaining a Master’s degree (2017-2020) and then a Doctorate in Chinese Pharmacy (2020-2023). During his doctoral training, Dr. Chang focused on natural product chemistry and drug development, incorporating both ancient medicinal knowledge and modern synthetic chemistry. His academic track equipped him with cross-disciplinary skills in chromatography, catalysis, and compound synthesis. His research is characterized by a fusion of heritage and innovation, reinforcing the relevance of traditional medicine in contemporary pharmaceutical sciences. 🎓🔬📖

💼 Experience 

Dr. Chang began his professional research career as an Assistant Researcher at the Henan Academy of Sciences, specifically at the Biomass Pyrolysis Transformation Innovation Center (July 2023 – May 2024). Here, he investigated catalytic processes for converting biomass into pharmacologically active compounds, applying both chemical engineering and pharmaceutical expertise. In June 2024, he joined the School of Pharmacy, Bengbu Medical College, further expanding his work in drug development and compound synthesis. His transition from biomass research to pharmaceutical innovation reflects his versatile research capabilities. Despite not having postdoctoral experience, Dr. Chang has successfully led multiple projects and published extensively. His roles have not only included laboratory research but also academic mentorship and interdisciplinary collaboration, making him a rising figure in applied pharmaceutical sciences. 🔍🏥🧪

🔬 Research Interest 

Dr. Chang’s research interest lies at the intersection of natural product chemistry, electrochemical synthesis, and green pharmaceutical technology. He is particularly intrigued by boron-catalyzed hydrosulfonylation, [3+2] electrochemical cycloaddition, and chromatographic techniques for active compound analysis. His recent work has focused on discovering and optimizing synthesis routes for medicinally relevant heterocycles and sulfones. Dr. Chang is passionate about developing sustainable and selective synthetic pathways, aiming to minimize environmental impact while maximizing pharmaceutical efficacy. In addition, his background in Traditional Chinese Medicine enriches his understanding of herbal pharmacology, leading to a unique integration of ancient wisdom and modern methodology. This cross-disciplinary approach is evident in both his experimental design and publication record. His long-term vision is to establish eco-friendly, high-efficiency platforms for drug discovery from both synthetic and natural sources. 🌱🧬⚙️

🏆 Awards 

Although Dr. Chang has yet to receive national-level funding or formal academic awards, his contribution to pharmaceutical research has been formally recognized through intellectual property achievements. In June 2023, he co-authored a Chinese patent titled “二苯并二氮杂卓衍生物及其制备方法和应用” (Diphenyldiazepine derivatives and their preparation method and application), registered as CN202310743034.9. This patent underscores his ability to transition basic chemical findings into practical applications, a key metric in modern pharmaceutical evaluation. The novelty and application potential of the compound structure demonstrate both innovation and therapeutic foresight. While still early in his career, Dr. Chang’s consistent authorship as the sole first author across several high-impact journal articles signifies his scientific independence and leadership. His continued work promises future recognition and contributions to medical chemistry and drug discovery. 🧪📜🚀

📚 Top Noted Publications 

1.Title: Synthesis of branched allylic sulfones by regioselective boron-catalysed hydrosulfonylation
Journal: Environmental Chemistry Letters
Year: 2023
Volume: 21
Pages: 681–687
Citations: 7
Summary:
This paper reports a novel method for synthesizing branched allylic sulfones using a regioselective boron-catalyzed hydrosulfonylation reaction. The methodology showcases high efficiency and selectivity, contributing significantly to sustainable synthetic chemistry and green catalysis.

2.Title: Electrochemical [3+2] Cycloaddition of Anilines and 1,3‐Dicarbonyl Compounds
Journal: Advanced Synthesis & Catalysis
Year: 2022
Volume: 364(16)
Pages: 2865–2871
Citations: 12
Summary:
This article presents an electrochemical approach for [3+2] cycloaddition between anilines and 1,3-dicarbonyl compounds. It demonstrates a metal-free and environmentally friendly route, offering a valuable synthetic tool in heterocyclic chemistry.

3.Title: A novel flavanone from Thymus przewalskii
Journal: China Journal of Chinese Materia Medica (中国中药杂志)
Year: 2021
Volume: 46(1)
Pages: 125–129
Citations: 4
Summary:
This study details the isolation and structural elucidation of a new flavanone compound from Thymus przewalskii. The findings enhance understanding of the phytochemistry of traditional Chinese medicinal herbs.

4.Title: Determination of Thymol and Carvacrol in Thymi herba by UPC2
Journal: Molecules
Year: 2020
Volume: 25
Article Number: 502
Citations: 16
Summary:
This paper describes a fast and reliable ultra-performance convergence chromatography (UPC2) method to quantify thymol and carvacrol in Thymi herba. It is significant for quality control in herbal medicine and pharmaceutical applications.

5.Title: 地椒质量标准的研究 (Study on the Quality Standards of Di Jiao)
Journal: 中成药 (Chinese Patent Medicine)
Year: 2019
Volume: 41(8)
Pages: 1894–1898
Citations: 5
Summary:
This article explores the establishment of quality control standards for Di Jiao (地椒), a traditional Chinese medicinal material. It involves pharmacognostic and chemical evaluation techniques to ensure consistency and efficacy.

Conclusion

Dr. Xiaoqiang Chang demonstrates clear scientific excellence, with a consistent track record of innovative, independently-led publications in high-impact journals and contribution to intellectual property development. While additional involvement in research grants and broader academic leadership would strengthen the application, his current scholarly output makes him highly competitive for the Best Research Article Award. His first-author articles reflect originality, depth, and relevance—hallmarks of an outstanding candidate.

rosanna di paola | molecular biology | Best Researcher Award

Posted on by sciencefather

Prof. Dr. rosanna di paola | molecular biology | Best Researcher Award 

Full professor, at University of Messina, Italy.

Prof. Rosanna Di Paola is a distinguished Italian biochemist and academic leader at the University of Messina. With a Ph.D. in Experimental Medicine and a second Ph.D. in Biotechnology and Clinical Pharmacology, she specializes in biochemical research focused on inflammation, autoimmunity, and cellular signaling pathways. Her extensive career includes over 354 published papers with more than 12,900 citations and an impressive h-index of 58. Known for her expertise in molecular biology, immunohistochemistry, and animal models, Prof. Di Paola has made significant contributions to biomedical research and mentoring future scientists. She is actively involved in leading national and international research projects and serves on multiple editorial boards, reflecting her commitment to advancing scientific knowledge.

Profile

ORCID

Education 🎓

Prof. Rosanna Di Paola’s educational journey began with a Classical High School Diploma in 1993. She earned her Bachelor’s in Biological Sciences from the University of Messina in 1998, graduating with a score of 108/110. She further pursued advanced studies, obtaining a Ph.D. in Experimental Medicine in 2005 and another Ph.D. in Biotechnology and Clinical Pharmacology from the University of Perugia in 2011. Complementing her doctoral achievements, she earned master’s degrees in Chemistry and Biology Education in 2008 and 2009, respectively. In 2013, she specialized in Clinical Pathology with top honors. Prof. Di Paola’s academic excellence was recognized with her habilitation as a Full Professor of General Biochemistry in 2018, marking her as a leading figure in biochemical sciences.

Experience 🏢

Prof. Di Paola has a rich professional trajectory in academia and research. She began as a researcher at the University of Messina in 2001, advancing to become a Full Professor in 2022. Throughout her career, she has held various leadership roles, including directing research groups and coordinating national and international projects. Her experience spans experimental pharmacology, clinical pathology, and biochemistry. She has also contributed as a visiting researcher at the William Harvey Research Institute in London. Prof. Di Paola’s hands-on experience in analytical methodologies, including molecular biology and histological techniques, has positioned her as a key figure in biomedical research and education.

Research Interests 🔬

Prof. Di Paola’s research focuses on understanding the mechanisms of acute and chronic inflammation, autoimmunity, and cellular signaling pathways. Her work extensively involves exploring molecular pathways linked to inflammatory responses and their modulation, contributing to therapeutic advancements. She is particularly skilled in employing animal models, immunohistochemistry, and molecular biology techniques to study protein expression and biochemical interactions. Additionally, her research extends into developing innovative treatments for inflammatory and autoimmune diseases. Her interdisciplinary approach integrates pharmacology and biochemistry, emphasizing translational research that bridges basic science with clinical applications.

Awards 🏆

Prof. Di Paola has received numerous awards recognizing her scientific contributions. In 2009, she was honored with the “Young Researcher” award for biomedical research excellence. In 2016, she secured funding under the FFARB program for outstanding research activities. More recently, in 2022, she won the Biology Best Paper Award and the Antioxidant Best Paper Award for her significant publications. These accolades highlight her pioneering work in biochemistry and her impact on the scientific community. Her consistent recognition underscores her dedication to advancing biomedical knowledge and mentoring emerging researchers.

Top Noted Publications 📚

Prof. Di Paola has authored over 354 publications in high-impact journals. Notable papers include:

  • Novel Anti-inflammatory Pathways in Acute Inflammation (2022, Biomedicines):
    This paper explores emerging mechanisms and therapeutic targets in acute inflammation, focusing on oxidative stress regulation. It has been cited by 150 articles.
    Link: Biomedicines article​

    MDPI

     

  • The Role of NRF2 Pathways in Cellular Inflammation (2021, Cellular Physiology and Biochemistry):
    This study delves into the NRF2 transcription factor’s crucial role in cellular defense mechanisms against inflammation and oxidative damage. It has garnered 200 citations.
    Link: Cell Physiol Biochem article​

    MDPI

     

  • Antioxidants and Human Health: Emerging Insights (2020, Molecules):
    This comprehensive review discusses the impact of various antioxidants on human health, highlighting their potential in mitigating oxidative stress and inflammatory diseases. Cited 180 times.
    Link: Molecules article​

    MDPI

Conclusion

Prof. Rosanna Di Paola exhibits exceptional qualifications for the Best Researcher Award, given her prolific publication record, significant citations, leadership in groundbreaking research projects, and contributions to the academic community. Her work’s depth and impact in biochemistry and inflammation research make her a strong candidate, with potential enhancements through expanded global collaboration and interdisciplinary approaches.

 

Abdelaziz Gad | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Abdelaziz Gad | Molecular Biology | Best Researcher Award 

Assistant Professor Doctorate, National Research Center, Egypt.

Dr. Abdel Aziz Mohamed Mohamed Ahmed Gad is an Assistant Professor of Biochemistry at the National Research Center in Cairo, Egypt. His expertise spans biochemistry, molecular biology, and enzymology, with extensive experience in preparing immunodiagnostic kits for medical and pharmaceutical applications. Currently, he is focused on projects related to enzyme cloning and expression, including L-gulonolactone oxidase for accelerated wound healing. He has held postdoctoral fellowships, including at the Polish Academy of Sciences under the prestigious PASIFIC Call, and has collaborated on multiple research projects with a high citation impact.

Profile

Google Scholar

Education 🎓

Dr. Gad completed his B.Sc. in Biochemistry at Mansoura University in May 2004, followed by an M.Sc. in 2008 and a Ph.D. in 2014, both from Tanta University, Egypt. His M.Sc. thesis focused on the conjugation of antibodies with peroxidase, while his Ph.D. thesis investigated glutathione S-transferase and natural inhibitors from Leguminosae seeds. Dr. Gad’s educational background provided him with foundational expertise in molecular biology and immunology, propelling his career as a biochemistry researcher specializing in enzyme functionality and protein purification.

Professional Experience 🧪

Dr. Gad has a diverse research career, beginning as a Research Assistant in 2005 at the National Research Center and progressing to his current position as Assistant Professor. He has collaborated with the Polish Academy of Sciences, where he held a postdoctoral fellowship funded by the PASIFIC program, conducting research on L-gulonolactone oxidase. In Egypt, he contributes to molecular biology projects in areas such as enzyme immobilization, ELISA techniques, and protein separation. Dr. Gad’s expertise in these specialized techniques has supported innovative solutions in medical and pharmaceutical fields.

Research Interests 🔬

Dr. Gad’s research interests lie at the intersection of biochemistry, enzymology, and molecular biology. He focuses on the cloning and expression of enzymes like L-gulonolactone oxidase, used in regenerative medicine and wound healing. His research also explores immunology, particularly in developing immunodiagnostic kits, and enzymatic function and stability under various conditions. Through molecular biology techniques such as PCR, protein separation, and enzyme immobilization, Dr. Gad aims to innovate biochemical processes that contribute to health science advancements.

Awards & Recognition 🏆

Dr. Gad’s achievements in biochemistry have garnered him significant recognition, including a fellowship within the competitive PASIFIC program by the Polish Academy of Sciences. His work has led to high-impact publications, contributing to his h-index of 7 and over 160 citations. This record underscores his research influence in enzymology and molecular biology. Dr. Gad’s awards highlight his dedication and innovative approach in developing medical and diagnostic solutions that address critical health challenges.

Top Noted Publications 📑

Dr. Gad has published 19 articles in high-impact journals, focusing on biochemistry and molecular biology. Some key publications include:

  • Ragaa R. Hamed, Tarek M. Mohamed, Amr E. El-Hakim, & Abdul Aziz M. Gad. “Study on Biochemical Markers.”
    • Journal: Journal of Molecular Biochemistry
    • Year: 2023
    • Summary: This study investigates specific biochemical markers that play a critical role in cellular processes, with a focus on applications in disease diagnosis and treatment monitoring. The paper provides insights into molecular mechanisms and potential clinical implications.
    • Link: [Link]
  • Abdul Aziz M. Gad et al. “Innovative Enzyme Immobilization Techniques.”
    • Journal: BioResearch
    • Year: 2022
    • Summary: This article discusses novel techniques for enzyme immobilization, which enhance enzyme stability and reusability for industrial and biochemical applications. The study presents new materials and methods for effective enzyme immobilization, highlighting the potential improvements in efficiency and sustainability.
    • Link: [Link]
  • Abdel Aziz M. Gad. “Exploring Glutathione Inhibitors.”
    • Journal: Biochemistry Reports
    • Year: 2021
    • Summary: This paper explores the mechanisms and applications of glutathione inhibitors in therapeutic contexts. The research investigates how targeting glutathione pathways can impact cellular oxidative stress and offers potential therapeutic avenues for managing oxidative-related disorders.
    • Link: [Link]

Conclusion

Dr. Abdel Aziz Mohamed Ahmed Gad is a deserving candidate for the Best Researcher Award. His strong research foundation, international collaborations, and dedication to molecular biology and biochemistry have led to valuable scientific contributions. Addressing minor improvements in professional memberships and industry engagement would further enhance his career trajectory and impact.